Real-world data shows Kalydeco reduces CF-related hospitalizations

In a paper published in Health Affairs, researchers at the Cystic Fibrosis Foundation and colleagues analyzed real-world evidence and found that cystic fibrosis drug Kalydeco ivacaftor from

Read the full 276 word article

User Sign In